BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 23381957)

  • 1. Gene transfer of master autophagy regulator TFEB results in clearance of toxic protein and correction of hepatic disease in alpha-1-anti-trypsin deficiency.
    Pastore N; Blomenkamp K; Annunziata F; Piccolo P; Mithbaokar P; Maria Sepe R; Vetrini F; Palmer D; Ng P; Polishchuk E; Iacobacci S; Polishchuk R; Teckman J; Ballabio A; Brunetti-Pierri N
    EMBO Mol Med; 2013 Mar; 5(3):397-412. PubMed ID: 23381957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autophagy master regulator TFEB induces clearance of toxic SERPINA1/α-1-antitrypsin polymers.
    Pastore N; Ballabio A; Brunetti-Pierri N
    Autophagy; 2013 Jul; 9(7):1094-6. PubMed ID: 23584152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bile Duct Ligation Induces ATZ Globule Clearance in a Mouse Model of α-1 Antitrypsin Deficiency.
    Khan Z; Yokota S; Ono Y; Bell AW; Oertel M; Stolz DB; Michalopoulos GK
    Gene Expr; 2017 Feb; 17(2):115-127. PubMed ID: 27938510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autophagy induced by exogenous bile acids is therapeutic in a model of α-1-AT deficiency liver disease.
    Tang Y; Fickert P; Trauner M; Marcus N; Blomenkamp K; Teckman J
    Am J Physiol Gastrointest Liver Physiol; 2016 Jul; 311(1):G156-65. PubMed ID: 27102560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An autophagy-enhancing drug promotes degradation of mutant alpha1-antitrypsin Z and reduces hepatic fibrosis.
    Hidvegi T; Ewing M; Hale P; Dippold C; Beckett C; Kemp C; Maurice N; Mukherjee A; Goldbach C; Watkins S; Michalopoulos G; Perlmutter DH
    Science; 2010 Jul; 329(5988):229-32. PubMed ID: 20522742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indomethacin increases liver damage in a murine model of liver injury from alpha-1-antitrypsin deficiency.
    Rudnick DA; Shikapwashya O; Blomenkamp K; Teckman JH
    Hepatology; 2006 Oct; 44(4):976-82. PubMed ID: 17006946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression or activation of TRPML1 reduces hepatic storage of toxic Z alpha-1 antitrypsin.
    Pastore N; Annunziata F; Colonna R; Maffia V; Giuliano T; Custode BM; Lombardi B; Polishchuk E; Cacace V; De Stefano L; Nusco E; Sorrentino NC; Piccolo P; Brunetti-Pierri N
    Mol Ther; 2023 Sep; 31(9):2651-2661. PubMed ID: 37394797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of PGC1α Downstream of the Insulin Signaling Pathway Plays a Role in the Hepatic Proteotoxicity of Mutant α1-Antitrypsin Deficiency Variant Z.
    Rudnick DA; Huang J; Hidvegi T; Chu AS; Hale P; Munanairi A; Dietzen DJ; Cliften PF; Tycksen E; Lutkewitte AJ; Finck BN; Pak SC; Silverman GA; Perlmutter DH
    Gastroenterology; 2022 Jul; 163(1):270-284. PubMed ID: 35301011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluphenazine reduces proteotoxicity in C. elegans and mammalian models of alpha-1-antitrypsin deficiency.
    Li J; Pak SC; O'Reilly LP; Benson JA; Wang Y; Hidvegi T; Hale P; Dippold C; Ewing M; Silverman GA; Perlmutter DH
    PLoS One; 2014; 9(1):e87260. PubMed ID: 24498058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-1 antitrypsin Z protein (PiZ) increases hepatic fibrosis in a murine model of cholestasis.
    Mencin A; Seki E; Osawa Y; Kodama Y; De Minicis S; Knowles M; Brenner DA
    Hepatology; 2007 Nov; 46(5):1443-52. PubMed ID: 17668872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancing lysosomal biogenesis and autophagic flux by activating the transcription factor EB protects against cadmium-induced neurotoxicity.
    Pi H; Li M; Tian L; Yang Z; Yu Z; Zhou Z
    Sci Rep; 2017 Feb; 7():43466. PubMed ID: 28240313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NFκB mitigates the pathological effects of misfolded α1-antitrypsin by activating autophagy and an integrated program of proteostasis mechanisms.
    Mukherjee A; Hidvegi T; Araya P; Ewing M; Stolz DB; Perlmutter DH
    Cell Death Differ; 2019 Mar; 26(3):455-469. PubMed ID: 29795336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LC3 lipidation is essential for TFEB activation during the lysosomal damage response to kidney injury.
    Nakamura S; Shigeyama S; Minami S; Shima T; Akayama S; Matsuda T; Esposito A; Napolitano G; Kuma A; Namba-Hamano T; Nakamura J; Yamamoto K; Sasai M; Tokumura A; Miyamoto M; Oe Y; Fujita T; Terawaki S; Takahashi A; Hamasaki M; Yamamoto M; Okada Y; Komatsu M; Nagai T; Takabatake Y; Xu H; Isaka Y; Ballabio A; Yoshimori T
    Nat Cell Biol; 2020 Oct; 22(10):1252-1263. PubMed ID: 32989250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trehalose induces autophagy via lysosomal-mediated TFEB activation in models of motoneuron degeneration.
    Rusmini P; Cortese K; Crippa V; Cristofani R; Cicardi ME; Ferrari V; Vezzoli G; Tedesco B; Meroni M; Messi E; Piccolella M; Galbiati M; Garrè M; Morelli E; Vaccari T; Poletti A
    Autophagy; 2019 Apr; 15(4):631-651. PubMed ID: 30335591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic progenitor cell proliferation and liver injury in α-1-antitrypsin deficiency.
    Brunt EM; Blomenkamp K; Ahmed M; Ali F; Marcus N; Teckman J
    J Pediatr Gastroenterol Nutr; 2010 Nov; 51(5):626-30. PubMed ID: 20890217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple Genes Core to ERAD, Macroautophagy and Lysosomal Degradation Pathways Participate in the Proteostasis Response in α1-Antitrypsin Deficiency.
    Li J; Moretti F; Hidvegi T; Sviben S; Fitzpatrick JAJ; Sundaramoorthi H; Pak SC; Silverman GA; Knapp B; Filipuzzi I; Alford J; Reece-Hoyes J; Nigsch F; Murphy LO; Nyfeler B; Perlmutter DH
    Cell Mol Gastroenterol Hepatol; 2024; 17(6):1007-1024. PubMed ID: 38336172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fenofibrate, a PPARα agonist, reduces hepatic fat accumulation through the upregulation of TFEB-mediated lipophagy.
    Yoo J; Jeong IK; Ahn KJ; Chung HY; Hwang YC
    Metabolism; 2021 Jul; 120():154798. PubMed ID: 33984335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VCP maintains lysosomal homeostasis and TFEB activity in differentiated skeletal muscle.
    Arhzaouy K; Papadopoulos C; Schulze N; Pittman SK; Meyer H; Weihl CC
    Autophagy; 2019 Jun; 15(6):1082-1099. PubMed ID: 30654731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging Concepts and Human Trials in Alpha-1-Antitrypsin Deficiency Liver Disease.
    Teckman JH
    Semin Liver Dis; 2017 May; 37(2):152-158. PubMed ID: 28564723
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of autophagy in alpha-1-antitrypsin deficiency.
    Hidvegi T; Mukherjee A; Ewing M; Kemp C; Perlmutter DH
    Methods Enzymol; 2011; 499():33-54. PubMed ID: 21683248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.